Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.
Clinical Cancer Research.
Times cited: 64
Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.
Cancer Immunology Immunotherapy.
Times cited: 27